Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
Cephalalgia : an International Journal of Headache
|
March 6, 2026
Where are the men? A systematic review of sex bias in human provocation models of migraine
Lanfranco Pellesi, Zeynep Celik, Melisa Fulya Sari, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
February 5, 2019
Pharmacokinetics and pharmacodynamics of new acute treatments for migraine
Chiara Lupi, Silvia Benemei, Simona Guerzoni, et al.
Expert Opinion on Emerging Drugs
|
June 14, 2026
Beyond Triptans in menstrual migraine: the emerging role of CGRP-Targeted therapies
Lanfranco Pellesi, Damiana Scuteri, Andrea Burgalassi, et al.
Headache
|
May 22, 2020
Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
Lanfranco Pellesi, Thien P Do, Håkan Ashina, et al.
Expert Review of Neurotherapeutics
|
November 28, 2025
Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal?
Lanfranco Pellesi, Flavia Lo Castro, Alberto Boccalini, et al.
Pain Practice : the Official Journal of World Institute of Pain
|
March 7, 2024
Triptan treatment is associated with a higher number of red wine-induced migraine episodes: An exploratory questionnaire-based survey
Laura Nedergaard, Maria Celine Martens, Michala Daniela Bach Christensen, et al.
Journal of Pain Research
|
August 6, 2020
Reducing Episodic Cluster Headaches: Focus on Galcanezumab
Lanfranco Pellesi, Roberto De Icco, Mohammad Al-Mahdi Al-Karagholi, et al.
The Journal of Headache and Pain
|
July 22, 2017
Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal
Carlo Baraldi, Lanfranco Pellesi, Simona Guerzoni, et al.
The Journal of Headache and Pain
|
April 18, 2025
Adoption of rimegepant in Denmark: a register-based study on uptake, prescribing patterns and initiator characteristics
Lanfranco Pellesi, Thien Phu Do, Martin Thomsen Ernst, et al.
Pain Management
|
April 16, 2025
Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment
Lanfranco Pellesi, Budour Jedie, Fadia Barhum, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
Cephalalgia : an International Journal of Headache
|
March 6, 2026
Where are the men? A systematic review of sex bias in human provocation models of migraine
Lanfranco Pellesi, Zeynep Celik, Melisa Fulya Sari, et al.
Expert Opinion on Drug Metabolism & Toxicology
|
February 5, 2019
Pharmacokinetics and pharmacodynamics of new acute treatments for migraine
Chiara Lupi, Silvia Benemei, Simona Guerzoni, et al.
Expert Opinion on Emerging Drugs
|
June 14, 2026
Beyond Triptans in menstrual migraine: the emerging role of CGRP-Targeted therapies
Lanfranco Pellesi, Damiana Scuteri, Andrea Burgalassi, et al.
Headache
|
May 22, 2020
Dual Therapy With Anti-CGRP Monoclonal Antibodies and Botulinum Toxin for Migraine Prevention: Is There a Rationale?
Lanfranco Pellesi, Thien P Do, Håkan Ashina, et al.
Expert Review of Neurotherapeutics
|
November 28, 2025
Medication-overuse headache: can anti-CGRP monoclonal antibodies replace withdrawal?
Lanfranco Pellesi, Flavia Lo Castro, Alberto Boccalini, et al.
Pain Practice : the Official Journal of World Institute of Pain
|
March 7, 2024
Triptan treatment is associated with a higher number of red wine-induced migraine episodes: An exploratory questionnaire-based survey
Laura Nedergaard, Maria Celine Martens, Michala Daniela Bach Christensen, et al.
Journal of Pain Research
|
August 6, 2020
Reducing Episodic Cluster Headaches: Focus on Galcanezumab
Lanfranco Pellesi, Roberto De Icco, Mohammad Al-Mahdi Al-Karagholi, et al.
The Journal of Headache and Pain
|
July 22, 2017
Therapeutical approaches to paroxysmal hemicrania, hemicrania continua and short lasting unilateral neuralgiform headache attacks: a critical appraisal
Carlo Baraldi, Lanfranco Pellesi, Simona Guerzoni, et al.
The Journal of Headache and Pain
|
April 18, 2025
Adoption of rimegepant in Denmark: a register-based study on uptake, prescribing patterns and initiator characteristics
Lanfranco Pellesi, Thien Phu Do, Martin Thomsen Ernst, et al.
Pain Management
|
April 16, 2025
Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment
Lanfranco Pellesi, Budour Jedie, Fadia Barhum, et al.
Page
of 6